ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing
Author(s): Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L
Source: BRITISH JOURNAL OF CANCER    Volume: 81    Issue: 1    Pages: 62-68    Published: SEP 1999  
Times Cited: 96     References: 30     
Abstract: Epidemiological studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal cancer incidence. We measured the rate ratio for colorectal adenocarcinoma according to dosage and the timing of exposure by means of a case-control study, nested in a non-concurrent cohort linkage study, using the population of beneficiaries of the Saskatchewan Prescription Drug Plan from 1981 to 1995 with no history of cancer since 1970 as the source population. Four controls per case, matched on age and gender and alive when the case was diagnosed, were randomly selected. Dispensing rates, calculated over successive time periods, characterized NSAID exposure. We accrued 3844 cases of colon cancer and 1971 cases of rectal cancer. For colon cancer a significant trend towards a decreasing rate ratio was associated with increasing exposure during the 6 months preceding diagnosis (P-trend = 0.002), For both cancers, significant trends were associated with exposure 11-15 years before diagnosis (colon: P-trend = 0.01; rectum: P-trend = 0.0001), At the highest exposure levels the rate ratio for colon cancer was 0.57 (95% confidence interval (CI) 0.36-0.89); for rectal cancer it was 0.26 (95% CI 0.11-0.61), No protection was associated with exposure during other periods. The timing of NSAID use must be considered in planning intervention trials to prevent colorectal cancer. There may be a 10-year delay before any preventive effect will appear.
Document Type: Editorial Material
Language: English
Reprint Address: Collet, JP (reprint author), Sir Mortimer B Davis Jewish Hosp, Ctr Clin Epidemiol & Community Studies, 3755 Chemin Cote Ste Catherine, Montreal, PQ H3T 1E2 Canada
Addresses:
1. Sir Mortimer B Davis Jewish Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2 Canada
2. McGill Univ, Joint Dept Epidemiol & Biostat & Occupat Hlth, Montreal, PQ Canada
Publisher: CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
Subject Category: Oncology
IDS Number: 230RB
ISSN: 0007-0920
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo